2016-03-07T00:00:00.000-05:00
court-ordered ban,-0.652183
sofosbuvir,-0.47112
Gilead products,-0.652183
Indian patent office,-0.685127
cure,-0.311333
Foster City-based company,-0.635186
patent dispute,-0.675625
competition intensifies,-0.635186
pill,-0.396323
treatments Victrelis,-0.583936
global sales,-0.583936
San Jose,-0.432243
federal court,-0.432243
liver disease treatment,-0.675625
Merck,-0.431207
generic forms,-0.342238
patents,-0.42752
work,-0.349473
Pharmasset,0.590116
Bloomberg Intelligence analyst,-0.586843
Gilead,0.240565
New Jersey-based client,0.329364
sofosbuvir patent,-0.685127
blockbuster drugs,-0.294515
percent drop,-0.686526
Asthika Goonewardene,-0.586843
Juanita Brooks,0.219108
hepatitis C drugs,-0.368693
U.S.,-0.635186
market,-0.453625
infringement claims,-0.335862
Gilead rolls,-0.265496
hepatitis C drug,-0.635186
